Written from a physician’s perspective For years, we’ve told patients with early-stage myeloproliferative neoplasms the same thing: “Let’s watch and wait.” The thinking was straightforward: why expose someone to treatment side effects when they’re not yet symptomatic? But a study published this December in the journal Cancers is making us reconsider that entire philosophy, especially […]